BRILL ENGINES
LIVE

Serial Number

79298897

Owner

BRILL ENGINES, S.L.

Filing Date

Sep 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BRILL ENGINES Trademark

Serial Number: 79298897 • Registration: 6874449

BRILL ENGINES is a trademark filed by BRILL ENGINES, S.L. on September 15, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BRILL ENGINES, S.L. (2 trademarks)

Planta 2, Puerta 1
BARCELONA 08022 , ES

Entity Type: 99

BRILL PHARMA, S.L. (13 trademarks)

C. Munner 10 08022-
BARCELONA , ES

Entity Type: 99

Trademark Details

Filing Date

September 15, 2020

Registration Date

October 18, 2022

Published for Opposition

August 2, 2022

Goods & Services

Sanitary preparations for medical use and products thereof, namely, sanitary sterilizing preparations; dental preparations, namely, medicated dental rinses as well as medicated dentifrices; products for air deodorizing and purification, namely, air deodorizing and purifying preparations; preparations for pest control, namely, anti-insect spray; dietetic preparations adapted for medical purposes and supplements, namely, dietary and nutritional supplements; disinfectants and antiseptics; disinfecting and medicinal detergents and soaps; absorbent products for personal hygiene, namely eye pads, eye compresses and eye patches for medical use; collyrium; ophthalmological preparations; chemical preparations for sanitary use; hygienic and sanitary products for medical use, namely cleaning solutions for medical use and/or for use in ocular or intraocular surgery; drugs being pharmaceutical preparations for ocular or intraocular surgery and/or for the treatment of eye diseases and conditions, allergic rhinitis and asthma; agents for administering medicines namely, drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals, dissolvable films, coatings for tablets, powders, tablets and capsules that facilitate the delivery of pharmaceutical preparations and provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines being pharmaceutical preparations for the treatment of eye diseases and conditions, allergic rhinitis and/or asthma, and/or for ocular or intraocular surgery

Medical and veterinary apparatus and instruments, namely, nebulizers for medical purposes and magnifying glasses for medical examination purposes; beds and furniture especially made for medical purposes; equipment for moving patients, namely, a low friction pad for sliding patients to or from a stretcher and bed; pacifiers for babies and utensils for assistance in feeding, namely, baby feeding pacifiers; equipment for medical diagnosis, examination and monitoring, namely eye pressure monitors, X-ray diagnostic apparatus; surgical instruments and instruments for the treatment of wounds, namely, medical devices for closing wounds and medical devices for measuring wounds; respiratory masks and apparatus for artificial respiration; ophthalmic instruments, namely, surgical instruments for use in ophthalmic surgery; ophthalmological instruments, namely, stethoscopes, ophthalmoscopes, retinoscopes; diagnostic instruments for ophthalmology; therapeutic instruments for ophthalmology, namely, instruments for treating eye diseases and conditions; droppers for administering medication, sold empty; medical cutting devices; measuring devices for medical use, namely blood pressure measuring apparatus; telemetry devices for medical applications; tonometers; medical imaging apparatus; droppers for medical use, namely, eye droppers; sutures and suture materials and medical devices for closing wounds; pharmaceutical instruments, namely injection device for pharmaceuticals; cups for dispensing medicine; apparatus for administering medicines, namely, spoons; droplet dispensing devices for medical use, namely droppers and dropper bottles for administering medication, sold empty; ointment dispensing devices in the nature of syringes, sold empty, for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jun 11, 2026 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Nov 22, 2024 NREP
CHANGE OF OWNER RECEIVED FROM IB
Oct 28, 2023 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 27, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 3, 2023 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 18, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 18, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Aug 9, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2022 CNSA
CHANGE OF OWNER RECEIVED FROM IB
Jun 18, 2022 CHLD
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 23, 2022 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2022 TROA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 4, 2022 OPNR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2021 CRFA
ASSIGNED TO LIE
Nov 9, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 4, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 5, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 5, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jun 5, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 1, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 10, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 10, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 10, 2021 RFCR
NON-FINAL ACTION WRITTEN
Feb 9, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 28, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 8, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 3, 2020 REPR